Genome-wide maps of chromatin accessibility of histone deacetylase inhibition in triple-negative breast cancer. Homo sapiens

Analysis of chromatin accessibility changes after prolonged exposure of triple-negative breast cancer cell lines to low doses of Panobinostat (LBH589), a pan-histone deacetylase inhibitor. Overall design: Examination of accessible chromatin after histone deacetylase inhibition in 2 triple-negative cell lines cell types.